Hoth Therapeutics, Inc. (RKTO) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.7x

Market Cap

$17.15M

MomentumView details →

1D Return

−0.30%

YTD Return

−31.23%

RSI (14)

31.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.7x

Market Cap

$17.15M

RSI (14)

31.4

MomentumView details →

1D Return

−0.30%

YTD Return

−31.23%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−162.43%

ROA (TTM)

−138.98%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+29.69%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.19

EPS Surprise

−33.43%

Beats (12Q)

0/12

Next Q EPS Est

−$0.15

Avg Surprise (4Q)

−33.43%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

6.20x

Quick Ratio

6.20x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−13.32M

Op. CF (TTM)

−10.66M

Next earningsDec 2, 2026 →

Latest newsMore news →

No recent news for RKTO.

Similar companies

Neuphoria Therapeutics Inc.NEUP AIxCrypto Holdings, Inc.AIXC Plus Therapeutics, Inc.CNSY Pa Shun International Holdings Limited00574.HK Sanai Health Industry Group Company Limited01889.HK 111, Inc.YI Find similar companies →

Latest newsMore news →

No recent news for RKTO.